23.02.2015 17:58:42

ESPERITE 2,154,000 shares exchanged today. Thank you for your interest in our company

Geneva, Switzerland - 23 February 2015

ESPERITE (ESP) 2'154'000 shares EXCHANGED TODAY. THE COMPANY publishes this note of appreciation addressed to all the investors who massively increased the volume of transactions at the Euronext stock exchange today.

Frederic Amar, CEO of ESPERITE:  "We are enthusiastic to notice this huge interest in our company.  I would like to thank personally all the investors who made this day so unique." 

About ESPERITE

ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and predictive medicine since 2000, operational in 40 countries with a network of 6,000 clinics worldwide.  ESPERITE serves clients in its state-of-the-art lab facilities in Geneva coupled with ultra-modern processing and storage facilities in Belgium, Switzerland, Germany, Dubai, South Africa and Portugal.  Its family stem cell bank, CryoSave, stores almost 275,000 samples from umbilical cord blood and cord tissue.

 

To learn more about the ESPERITE group, or to book an interview with CEO Frederic Amar: +31 575 548 998 - ir@esperite.com or visit the websites at www.esperite.com and www.genoma.com.




This announcement is distributed by Nasdaq OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Esperite N.V. via Globenewswire

HUG#1896583

Nachrichten zu Esperitemehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Esperitemehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Esperite 0,04 0,00% Esperite